Fundamental Data for ALXA

ALEXA PHAR(NSDQ:ALXA)

Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

# Employees: 111

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 3/9/2010

Mean EPS (Next Qtr): ($0.23)

Mean EPS (Year): ($0.95)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 2

Shares Performance

Period	ALXA	Compare to S&P
YTD	-28.08 %	-40.47 %
4 Weeks	-5.00 %	-6.03 %
12 Weeks	-15.56 %	-20.39 %

Shares Information

Analyst Coverage: Y

Avg Volume: 105742

Shares Outstanding: 33M

Market Cap: $0.08B

52 Week High: $3.35

52 Week Low: $1.40

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 ALXA split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: -603.57 %

EPS Growth in Last Year: -337.78 %

Sales Growth in Last Quarter: 2,181.53 %

Sales Growth in Last Quarter: -0.01 %

Financials

Qtr Book Value: $3.95

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010